ARCHIVES

Investigational Drug Radium-223 Chloride Improved Overall Survival By 44 Percent

This article is from The Cancer Letter archive.

Vol. 34 No. 9 | September 30, 2011

Download PDF Visit The Full Archive

Related Articles

Lawyer Says Salick didn’t Anticipate Ouster By Zeneza

May 2, 1997

In Brief: OSCC Staff Appointments Announced Report Available On Chemical Disposal Health Aspects

August 3, 1984

Expert Review Of ImClone Protocol Concludes C225 Approval Unlikely.

February 15, 2002

Supreme Court Decision Means FTC Scrutiny As Costly Oncology Drugs Go Off-Patent

June 21, 2013

5-Day Strut-based Brachytherapy Produced Low Recurrence Rates

May 25, 2012

In Brief: Lucius Sinks New Cancer Centers Branch Chief; Mary Sears, One Of ASCO Founders, to Retire

May 11, 1984